CE approval for Complete Conduction System Pacing system for left bundle branch area pacing

The Biotronik Complete Conduction System Pacing (CSP) system comprises three proven components: Selectra 3D catheters offering exceptional handling, Solia S leads – the most popular choice of stylet-driven leads for LBBAP providing enhanced stability , and the Amvia pacemaker family, the first and only family approved for LBBAP. Notably, this groundbreaking system is the world’s first and only approved MR Conditional CSP system for LBBAP.

LBBAP, utilizing the heart's natural conduction system efficiency, is recognized as the preferred approach to physiologic pacing. Biotronik's commitment to CSP has enabled the company to develop a dedicated CSP portfolio. Providing comprehensive training and expert technical support, Biotronik is dedicated to fostering confidence among experienced physicians as well as those new to CSP.

“By introducing the world’s first approved and complete CSP system, we are revolutionizing cardiac rhythm care while leading the CSP field. Biotronik is listening to clinicians' needs, ensuring continuous advancement for the benefit of our patients and healthcare providers," stated Dr. Alexander Uhl, CEO at Biotronik

Biotronik’s CSP Solution will be showcased at the EHRA Congress in Berlin from April 7-9, 2024. Visitors can attend the CSP-dedicated lunch symposium focused on mastering the stylet-driven approach for LBBAP, as well as the Biotronik booth expert talks led by experienced CSP implanters to gain practical insights and best practice tips & tricks for LBBAP.